Hemispherx BioPharma (HEB)

[Richard2]

Management still adding

n *
Equels Thomas K. 2. Issuer Name and Ticker or Trading Symbol
HEMISPHERX BIOPHARMA INC [ HEB ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
CEO, President
(Last) (First) (Middle)
4649 PONCE DE LEON BLVD., #495 3. Date of Earliest Transaction (MM/DD/YYYY)
12/22/2016
(Street)
CORAL GABLES, FL 33146
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/22/2016 P 68493 A $0.73 220455 D